HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Binderup Selected Research

seocalcitol

8/2003Effects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumors.
1/2001MCF-7/VD(R): a new vitamin D resistant cell line.
8/2000The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells.
5/2000Seocalcitol (EB 1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation.
4/2000Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Binderup Research Topics

Disease

10Neoplasms (Cancer)
08/2003 - 04/2000
4Breast Neoplasms (Breast Cancer)
08/2001 - 08/2000
3Colonic Neoplasms (Colon Cancer)
10/2001 - 04/2000
1Hypercalciuria
08/2003
1Weight Loss (Weight Reduction)
08/2003
1Hypercalcemia (Milk Alkali Syndrome)
08/2003
1Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2001
1Hematologic Neoplasms (Hematological Malignancy)
11/2001
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2001
1Leukemia
11/2001
1Carcinogenesis
07/2001
1Skin Diseases (Skin Disease)
05/2001
1Psoriasis (Pustulosis Palmaris et Plantaris)
05/2001
1Osteoporosis
04/2001
1Osteosarcoma (Osteogenic Sarcoma)
04/2001
1Lymphoma (Lymphomas)
01/2001
1Neoplasm Metastasis (Metastasis)
08/2000
1Paralysis (Palsy)
08/2000
1Hepatocellular Carcinoma (Hepatoma)
05/2000
1Carcinoma (Carcinomatosis)
04/2000
1Colorectal Neoplasms (Colorectal Cancer)
04/2000
1Adenoma (Adenomas)
04/2000

Drug/Important Bio-Agent (IBA)

7Vitamin DFDA LinkGeneric
08/2003 - 04/2000
5seocalcitolIBA
08/2003 - 04/2000
4N- (6- chlorophenoxyhexyl)- N''- cyano- N''- 4- pyridylguanidine (CHS 828)IBA
11/2001 - 09/2000
4hydroxide ionIBA
10/2001 - 05/2000
3dicyandiamido (cyanoguanidine)IBA
11/2001 - 11/2000
2Calcitriol (Calcijex)FDA LinkGeneric
08/2003 - 07/2001
2Cholecalciferol (Vitamin D3)FDA Link
10/2001 - 04/2000
21,25-dihydroxyvitamin DIBA
08/2001 - 08/2000
1EB 1053IBA
08/2003
1Pamidronate (Aredia)FDA LinkGeneric
08/2003
1Diphosphonates (Bisphosphonates)IBA
08/2003
1Urea (Carbamide)FDA LinkGeneric
08/2003
1Insulin-Like PeptidesIBA
10/2001
1Insulin-Like Growth Factor II (Somatomedin A)IBA
10/2001
1CalciumIBA
07/2001
1Hormones (Hormone)IBA
05/2001
1Calcitriol Receptors (Calcitriol Receptor)IBA
05/2001
1calcipotriene (calcipotriol)FDA LinkGeneric
05/2001
1Anabolic AgentsIBA
04/2001
1Proteins (Proteins, Gene)FDA Link
01/2001
1DNA (Deoxyribonucleic Acid)IBA
01/2001
1Paclitaxel (Taxol)FDA LinkGeneric
11/2000
13-Iodobenzylguanidine (Iobenguane)IBA
09/2000
1Pharmaceutical PreparationsIBA
05/2000

Therapy/Procedure

2Therapeutics
08/2003 - 04/2000
1Withholding Treatment
08/2003
1Chemoprevention
04/2000